or Try an Advanced Search...

    Technical Analysis for CSTL - Castle Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 24.24 0.08% 0.02
    CSTL closed up 0.08 percent on Friday, May 17, 2024, on approximately normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Flat
    Historical CSTL trend table...
    Date Alert Name Type % Chg
    Three Weeks Tight Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 0.08%
    Inside Day Range Contraction -0.49%
    Wide Bands Range Expansion -0.49%
    Outside Day Range Expansion 1.38%
    Wide Bands Range Expansion 1.38%
    Gapped Up Strength 1.38%
    NR7 Range Contraction -0.04%
    Older End-of-Day Signals for CSTL ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    60 Minute Opening Range Breakdown 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CSTL Chart by TradingView
    Basic chart:

    Profile

    Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Test Gene Expression Metastasis Dsw Uveal Melanoma

    Is CSTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
    May 14 Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024
    May 10 Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"
    May 8 Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result
    May 7 Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know
    May 6 Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable
    May 5 Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
    May 5 Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript
    May 4 Castle Biosciences, Inc. (CSTL) Q1 2024 Earnings Call Transcript
    May 3 DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
    See more CSTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.7
    52 Week Low 9.2601
    Average Volume 224,622
    200-Day Moving Average 19.67
    50-Day Moving Average 21.29
    20-Day Moving Average 22.63
    10-Day Moving Average 24.14
    Average True Range 1.08
    RSI (14) 63.64
    ADX 30.25
    +DI 28.74
    -DI 13.47
    Chandelier Exit (Long, 3 ATRs) 22.66
    Chandelier Exit (Short, 3 ATRs) 21.75
    Upper Bollinger Bands 26.34
    Lower Bollinger Band 18.92
    Percent B (%b) 0.72
    BandWidth 32.78
    MACD Line 0.97
    MACD Signal Line 0.85
    MACD Histogram 0.124
    Fundamentals Value
    Market Cap 652.31 Million
    Num Shares 26.9 Million
    EPS -2.84
    Price-to-Earnings (P/E) Ratio -8.54
    Price-to-Sales 3.35
    Price-to-Book 1.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.37
    Resistance 3 (R3) 25.48 25.21 25.18
    Resistance 2 (R2) 25.21 24.92 25.15 25.12
    Resistance 1 (R1) 24.72 24.74 24.59 24.62 25.06
    Pivot Point 24.45 24.45 24.38 24.40 24.45
    Support 1 (S1) 23.97 24.16 23.83 23.86 23.42
    Support 2 (S2) 23.70 23.99 23.64 23.36
    Support 3 (S3) 23.21 23.70 23.30
    Support 4 (S4) 23.11